Endo International plc
SEC CIK 1593034 · ENDP · last insider filing 2022-08-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Coleman Blaise | Director · SVP Glob Finance & Interim CFO | filed 2016 - 2022 |
| Hyatt Michael | Director | filed 2014 - 2021 |
| Montague William P | Director | filed 2014 - 2021 |
| Hutson Nancy J | Director | filed 2014 - 2021 |
| Cooke Shane | Director | filed 2014 - 2021 |
| Barberio Mark G | Director | filed 2020 - 2021 |
| Chao Jennifer M | Director | filed 2021 - 2021 |
| Smith Mary Christine | Director | filed 2020 - 2021 |
| Campanelli Paul | Director · President, Par Pharmaceutical | filed 2015 - 2021 |
| Kimmel Roger H | Director | filed 2014 - 2020 |
| Mansukani Sharad | Director | filed 2017 - 2019 |
| Ingram Douglas S | Director | filed 2016 - 2017 |
| Smith Jill D. | Director | filed 2014 - 2017 |
| Higgins Arthur J | Director | filed 2014 - 2016 |
| Sisitsky Todd Benjamin | Director | filed 2016 - 2016 |
| DE Silva Rajiv | Director · President & CEO | filed 2014 - 2016 |
| Spengler William | Director | filed 2014 - 2016 |
| Delucca John | Director | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tursi James Patrick | Executive VP, Global R&D | filed 2022 - 2022 |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | filed 2015 - 2022 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | filed 2018 - 2022 |
| Bradley Mark T. | EVP, Chief Financial Officer | filed 2020 - 2022 |
| Raciti Frank B. | VP, Controller and CAO | filed 2021 - 2022 |
| Apostol George | EVP, Head of Global R&D | filed 2020 - 2021 |
| Boyle Jack D. | SVP, Interim Controller | filed 2019 - 2021 |
| Ciarico Domenico | EVP & Chief Commercial Officer | filed 2019 - 2020 |
| Coughlin Terrance J | EVP, Chief Operating Officer | filed 2016 - 2020 |
| Garella Rahul | EVP, Intl Pharmaceuticals | filed 2019 - 2020 |
| Nichol Carrie Ann | VP, Controller & CAO | filed 2018 - 2019 |
| Pera Antonio R | President, Par Pharmaceutical | filed 2016 - 2019 |
| Rudio Daniel | Vice President, Controller | filed 2014 - 2018 |
| Upadhyay Suketu | EVP, Chief Financial Officer | filed 2014 - 2016 |
| Ciaffoni Joseph | President, U.S. Branded Pharma | filed 2016 - 2016 |
| Varghese Hemanth Jacob | Pres. International Pharma | filed 2016 - 2016 |
| Hall Susan | EVP, CSO, Global Head of R&D | filed 2014 - 2016 |
| Lortie Brian | President Branded Pharma | filed 2015 - 2016 |
| Manogue Caroline B | Exec. V.P.,Chief Legal Officer | filed 2014 - 2015 |
| Farhat Camille | President, AMS, Inc. | filed 2014 - 2015 |
| Degolyer Donald W | Chief Operating Officer,Pharma | filed 2014 - 2015 |
| Gergel Ivan P. | EVP, R&D and CSO | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.